Accendra Health Inc Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
Analyst Coverage
5analysts covering
FY EPS (est.)
$0.42next fiscal year
Monitoring Framework
Key Performance Indicators
EBITDA Margin Quarterly11.2%Target: 14%-15% by 2027
Net Leverage Ratio Quarterly4.9xTarget: Below 3.0x
Watch Items
- Commercial Payor Contract ConcentrationTrigger: Loss of additional commercial payor contracts beyond the major contract lost in 2026Action: Accelerate cost-reduction measures to mitigate stranded costs and diversify referral networks
- Diabetes Product Line Pricing PressureTrigger: Accelerated shift of patients by payors from the durable medical equipment (DME) channel to the pharmacy channelAction: Optimize product mix and renegotiate manufacturer pricing structures to preserve margins
Research as of 24 Jul 2026